Abstract Myalgic encephalitis/chronic fatigue syndrome (ME/CFS) is a common debilitating medical condition, whose main symptoms - fatigue, post-exertional malaise and cognitive dysfunction are also present in many cases of long COVID
Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, et al
Cordeiro F, et al
Key Takeaways Weight loss plateaus on Semaglutide are a normal metabolic adaptation, typically occurring between 20 and 60 weeks of treatment
Additionally, IL-6 infusion elevates GLP-1 in mice but not in humans, underscoring species-specific regulation of inflammation
FIGURE 1 Intraoperative constraints are strict, requiring system engineering trade-offs across multiple factors